Sertraline and speech blockage.
Makela
E H
EH
Sullivan
P
P
Taylor
M
M
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004401:Dysarthria / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D020280:Sertraline; D014705:Verbal Behavior / Q000187:drug effects
D000928:Antidepressive Agents; D015057:1-Naphthylamine; D020280:Sertraline